Results 31 to 40 of about 7,292 (203)

Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia

Dermatologica Sinica
Background: The first-line pharmacologic treatment for both male and female pattern hair loss is topical minoxidil. Nonetheless, off-label usage of low-dose oral minoxidil has demonstrated good clinical efficacy and safety.
Bhumika Mahawar, Ashish Ramchandra Deshmukh   +1 more
doaj   +1 more source

The efficacy of topical minoxidil 2% versus topical botanically derived inhibitors of 5 alpha reductase in treatment of female pattern hair loss by trichoscopy

Journal of the Egyptian Women’s Dermatologic Society, 2019
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FDA approved medical treatment for FPHL. However, the off-label botanically derived 5-alpha reductase inhibitors (5αRIs) are commonly used despite ...
Fairouz K Badran, Rania E Abd El Maksoud, Mona M Ibrahim Moawad   +2 more
doaj   +1 more source

Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis

Journal of Dermatological Treatment
Objective This systematic review evaluates the efficacy of minoxidil alone versus minoxidil with low-level laser therapy (LLLT) for androgenic alopecia.Study design systematic review and meta-analysis.Methods An online search of PubMed, Web of Science ...
Abdulmajeed Alosaimi, Abdullah Algarni, Abdulrahman Alharbi, Abdulmalik Alotaibi, Abdullah Alomairi, Mohannad Alsurayhi, Waleed Alharbi   +6 more
doaj   +1 more source

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

JEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin J. Jimenez   +2 more
wiley   +1 more source

Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation

Acta Dermato-Venereologica
Topical minoxidil is the mainstay of treatment for androgenic alopecia and is also used off-label for other forms of hair loss. Despite its efficacy and favourable safety profile, the use of minoxidil is associated with various side effects, the most ...
Alexandra Junge, Susanne Radonjic-Hoesli, Simon Bossart, Dagmar Simon, Pierre de Viragh, Robert E. Hunger, Kristine Heidemeyer, S. Morteza Seyed Jafari   +7 more
doaj   +1 more source

Oral Minoxidil for Androgenetic Alopecia

, 2022
Purpose: The purpose of this article is to review the current treatment options of androgenetic alopecia and to explore the risk and potential benefits of oral Minoxidil therapy.
Ingram, Laurice D
core  

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Experiments with minoxidil [PDF]

, 1989
A dissolução de minoxidil sob forma de pó microcristalino foi avaliada em diversas temperaturas. A avaliação de minoxidil em soluções com diferentes concentrações foi feita espectrofotometricamente (U.V.).The dissolution of minoxidil as microcrystaline ...
Nunes, Renata L., Ribeiro, Maira H., Bergold, Ana Maria, Camargo, Laura N., Dias, Maria Christina S., Ponzio, Humberto Antonio Salomon, Maciel, Regina A.G., Sartori, Vera L.G.   +7 more
core  

Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery

VIEW, EarlyView.
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf, Salman Farsi Taharat, Md. Sadek Miah, Hasan Tasnim Salehin, M. Azam Ali, Shoeb Ahmed   +5 more
wiley   +1 more source

Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial

Journal of Dermatological Treatment, 2023
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram, Rashmi Kumari, Sivaranjini Ramassamy   +2 more
doaj   +1 more source